FORT WORTH, Texas, Nov. 05, 2025 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter ended September 30, 2025, and recent management changes. HighlightsThird Quarter 2025 Sales volumes averaged approximately 47.8 thousand barrels of crude oil equivalent per day (“MBoe/d”), consistent with the second quarter.Net loss was $18.3 million, or ($0.15) per diluted share and EBITDAX (a non-GAAP financial measure define ...

PITTSBURGH, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ: DUOL) announced results for the third quarter ended September 30, 2025 in a shareholder letter that is posted on its Investor Relations website at investors.duolingo.com. “We passed a major milestone this quarter: more than 50 million people now use Duolingo every day,” said Luis von Ahn, Co-Founder and CEO of Duolingo. “That kind of scale gives us a unique opportunity to deliver impact, and we’re doing that by making our product even mor ...

Planned U.S. launch of Anaphylm™ in the first quarter of 2026, if approved by the FDA Advanced Anaphylm regulatory activities in Canada and the EUAdded clinical leadership to drive long-term successStrengthened balance sheet to support planned commercial launch execution of AnaphylmCompany to host investor call on November 6, 2025, at 8:00am ET WARREN, N.J., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medici ...

Earnings Release Highlights Third quarter GAAP Net Income Attributable to Stockholders of $207 million.Third quarter Adjusted EBITDA of $363 million and Adjusted Free Cash Flow of $223 million.Narrowing 2025 guidance and affirming 2026 guidance.Raised $1.2 billion senior secured term loan B credit facility and issued $2.7 billion in senior unsecured notes to finance the Freedom and Guernsey acquisitions (the “Acquisitions”).Increased share repurchase program (“SRP”), with $2 billion remaining through 2028. ...

RESTON, Va., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, today announced financial results for the quarter ended September 30, 2025. CEO Commentary “Our markets continue to demonstrate strong demand and abundant sources of funding for infrastructure planning and improvement,” said Gary Bowman, founder and CEO of Bowman. “Since our public debut nearly five years ago, we have delivered sustained revenue and backlog ...

Strategic review process concluded with intention to wind down cell therapy business, representing optimal capital allocation pathway to support a stronger and sustainable future for GalapagosContinued evolution of leadership team aligned with strategic directionRobust balance sheet with €3.05 billion in cash and financial investments as of September 30, 2025; year-end 2025 cash position expected at €2.975 billion to €3.025 billion Management to host a conference call tomorrow, November 6, 2025, at 14:00 C ...

DRAPER, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest Health Savings Accounts (“HSA") and consumer-directed benefits administrator, today announced plans to release financial results of its third quarter of fiscal 2026 following the close of regular stock market trading hours on Wednesday, December 3, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Wednesday, December ...

NEWTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, today announced that the Company will report third quarter 2025 financial results on Wednesday, November 12, 2025. The Company will host a conference call and live audio webcast at 8:00 a.m. ET to provide a business and fina ...

Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on Track Ex-U.S. Regulatory Reviews of Aficamten Ongoing in China and E.U. ~$1.25 Billion in Cash, Cash Equivalents and Investments as of September 30, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a management update and financial results for the third quarter of 2025. “I’m pleased that our teams continue to demon ...

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM) today announced it will report its financial results for the third quarter ended September 30, 2025, after the close of the U.S. capital markets on Wednesday, November 12, 2025. In addition, OTC Markets Group will host a conference call and webcast on Thursday, November 13, 2025, at 8:30 a.m. eastern time, during which management will discuss the financial results in further detail. Webcast:The conference webcast and management ...